English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduPersonalized text messages effectively promoted increased physical activity for patients after significant heart events — such as a heart attack or surgery — but those effects later diminished.
Tag: Heart Disease
Exercise More, Sit Less to Manage Frailty and Hypertension Risk in Aging
A new study of middle-age and older adults looks at sex differences in frailty levels and their link with heart health. The findings suggest that moving your body more through regular exercise and sitting less can help keep both heart disease and frailty at bay as we age.
Study Suggests States Could Cut Healthcare Costs by Delivering Patient Tailored Meals
According to new research looking at every U.S. state, programs that deliver medically tailored meals (MTMs) to people with diet-sensitive conditions such as diabetes and heart disease along with limitations in the ability to perform daily activities could lead to substantial savings in healthcare costs.
From the Pakistan-India Border to Our Borderplex: A Doctor’s Journey Dr. Muhammad Moiz Tahir tackles El Paso’s health challenges with community-driven care
EL PASO, Texas — Some people claim borders are barriers. Others see them as frontiers worthy of exploration. Muhammad Moiz Tahir, M.D., is one of the newest assistant professors in the Foster School of Medicine’s Department of Internal Medicine. Dr.…
New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes
Using an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in 17 genes that shed light on the molecular basis of coronary artery disease (CAD), the leading cause of morbidity and mortality worldwide. The discoveries, detailed in the June 11 online issue of Nature Genetics, reveal genetic factors impacting heart disease that open new avenues for targeted treatments and personalized approaches to cardiovascular care. The investigators used an in silico, or computer-derived, score for coronary artery disease (ISCAD) that holistically represents CAD, as described in a previous paper by the team in The Lancet. The ISCAD score incorporates hundreds of different clinical features from the electronic health record, including vital signs, laboratory test results, medications, symptoms, and diagnoses. To build the score, they trained machine learning models on the electronic health records of 604,914 individuals
Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)
President of Mount Sinai Fuster Heart Hospital given top honor for his scientific excellence and successful global education initiatives on cardiovascular disease
People with well-controlled, long-duration type 1 diabetes may still face high risk of heart disease
People who have had type 1 diabetes for more than 50 years without kidney complications may still be at substantial risk for heart disease, despite excellent control of blood pressure, cholesterol and blood sugar levels, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Risk for heart attack and stroke increases in people with obesity for a decade or more
People under age 50 have a greater risk for heart attack or stroke if they’ve lived with obesity for 10 years, according to industry-sponsored research being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
New York Valves 2024 Late-Breaking Clinical Trials and Science Announced
The Cardiovascular Research Foundation® (CRF®) has announced New York Valves: The Structural Heart Summit will feature 12 Late-Breaking Clinical Trials and Science presentations. New York Valves 2024, the expanded iteration of our renowned annual Transcatheter Valve Therapy (TVT®) conference, will take place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City.
4C Medical’s AltaValve System Secures Dual FDA Breakthrough Device Designations, Expediting Patient Access to Advanced Mitral Valve Therapies
4C Medical Technologies, Inc. (“4C Medical”), a medical device company dedicated to advancing minimally invasive therapies for structural heart disease, has been granted Breakthrough Device designation by the U.S.
TCT 2024 Master Operator Award to Be Presented to Jeffrey W. Moses, MD
The TCT Geoffrey O. Hartzler Master Operator Award will be presented to Jeffrey W. Moses, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 27-30, 2024, in Washington, DC, at the Walter E. Washington Convention Center.
Program announced for NUTRITION 2024 to be held June 29–July 2
Reporters are invited to join leading nutrition researchers and professionals at NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition.
After spinal cord injury, neurons wreak havoc on metabolism
Conditions such as diabetes, heart attack and vascular diseases commonly diagnosed in people with spinal cord injuries can be traced to abnormal post-injury neuronal activity that causes abdominal fat tissue compounds to leak and pool in the liver and other organs, a new animal study has found.
Covid Vaccines Not Linked to Fatal Heart Problems in Young People, CDC Finds
William Borden, is a professor of medicine and health policy at the GW School of Medicine and Health Sciences. He specializes in preventive cardiology, the treatment of complex cholesterol disorders, and diagnosing and treating general cardiovascular diseases. Brian Choi, is…
Around 10% of deaths from coronary stenting, balloon angioplasty are preventable
Around 10% of all deaths following percutaneous coronary intervention are potentially preventable, a study led by Michigan Medicine finds.
Press passes available now for NUTRITION 2024 to be held June 29–July 2
Complimentary press passes are now available for NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition.
New Technology Promises to Revolutionize Valvular Heart Disease Care
Experts advance models for speedy adoption for better diagnosis and therapy in The Lancet.
FDA Approves Semaglutide for Heart Disease Prevention
Last week, the U.S. Food and Drug Administration approved the drug semaglutide, commonly known as Wegovy or Ozempic, to be used to reduce the risk of cardiovascular death, heart attack and stroke in adults with heart disease and obesity. Eric…
8 Key Facts About Statins and Cholesterol
Statins can help lower cholesterol and reduce the risk of heart attacks, stroke and other heart and vascular problems. But they aren’t right for all patients, and they can rarely cause side effects. Cardiologist Melissa Tracy answers patients’ most frequently asked questions about statins.
Women’s Hearts Differ From Men’s
Heart disease is the No. 1 cause of death in the U.S. for both men and women, but from pregnancy risks to how their arteries function women face different challenges in the prevention, diagnosis and treatment of cardiovascular conditions.
Cleveland Clinic Among First Hospitals to Perform New Tissue-Sparing Ablation Procedure
Cleveland Clinic Among First Hospitals to Perform New Tissue-Sparing Ablation Procedure
Healthcare leaders plea to reinstate the Canadian hypertension control program to prevent death and disability
A passionate plea for the re-establishment of Canada’s health coalition focused on hypertension prevention and control appears as an editorial in the Canadian Journal of Cardiology, published by Elsevier.
Intravascular Imaging Significantly Improves Survival, Safety, and Outcomes in Cardiovascular Stenting Procedures Over Conventional Angiography
Results from this large-scale synthesis of all prior clinical trials could increase usage of several types of high-resolution imaging for guiding interventional coronary procedures
Could Ultra-processed Foods Be the New ‘Silent’ Killer?
Hundreds of novel ingredients never encountered by human physiology are now found in nearly 60 percent of the average adult’s diet and nearly 70 percent of children’s diets in the U.S. An emerging health hazard is the unprecedented consumption of these ultra-processed foods in the standard American diet. This may be the new “silent” killer, as was unrecognized high blood pressure in previous decades.
MSU researchers create more realistic synthetic human mini hearts, gain worldwide recognition
Thanks to advancements in the development of patented synthetic human-like hearts first created at Michigan State, researchers can study human heart development and congenital heart disease on highly accurate models. This is facilitating the development of new therapies and pharmaceutical drugs to treat a variety of heart-related diseases just in time for the observance of American Heart Month in February.
Cleveland Clinic-Led Study Discovers Link between High Levels of Niacin – a Common B Vitamin – and Heart Disease
Cleveland Clinic researchers have identified a new pathway that contributes to cardiovascular disease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol.
Clues to cancer drug’s deadly side effects could make it safer
For some leukemia patients, their only treatment option carries a risk of heart failure
Should heart patients consider taking weight loss medications?
Over the last year, prescriptions for medications that can accelerate weight loss in people with diabetes, or without it, have skyrocketed. But how can these weight loss medications affect the heart? A preventive cardiologist shares how this shifting landscape might affect cardiovascular care and how he advises his patients.
Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes
In a study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas, researchers examined outcomes for patients undergoing SAVR and those undergoing TAVR from 2013 to 2021 in the state of California.
Mount Sinai Renames Top-Ranked Heart Hospital to Honor Valentin Fuster, MD, PhD, and His Legacy of Excellence
“Mount Sinai Fuster Heart Hospital” furthers vision of world-leading cardiac care and research that prevents heart disease worldwide
BGSU research examines connection between loneliness and predictors of increased risk of heart disease
Research will focus on understanding what it takes for lonely individuals to build social connections and how those interactions affect the sympathetic nervous system
High Pregnancy Weight Gain Tied to Higher Risk of Later Death
Findings from 50 years of data highlighted the health risks when more weight is gained in pregnancy than recommended, especially when it comes to heart disease- and diabetes-related mortality
Walgreens and the Cardiovascular Research Foundation Unite to Improve Recognition and Diagnosis of Valvular Heart Disease for Older Americans
Walgreens and the Cardiovascular Research Foundation (CRF) today announced a collaboration to drive forward the PREVUE-VALVE study, a groundbreaking population-based clinical trial that aims to quantify the prevalence of valvular heart disease (VHD) among older Americans and pave the way for the development of new therapies and tools for VHD detection and diagnosis.
After 50 years of pioneering research in rural Louisiana, study pivots from heart to brain
A study spent 50 years tracking the health of a rural Louisiana town’s children into adulthood and found that heart disease starts in childhood. Now the study hopes decades of heart research can unlock the origins of dementia.
UCLA-led team finds a stem-cell derived mechanism that could lead to regenerative therapies for heart damage
A UCLA-led team has identified an essential internal control mechanism that can promote the maturation of human stem cell-derived heart muscle cells, possibly leading to new therapies for heart disease and cardiac damage.
CRF Announces the 2023 Pulse-Setter Award Winners
The Cardiovascular Research Foundation (CRF) is proud to announce the winners of the 2023 Pulse-Setter Awards. The awardees will be honored at The Annual Pulse of the City Gala, CRF’s signature fundraising event, on December 8, 2023, at The Plaza in New York City. The Pulse-Setter Awards shine a spotlight on extraordinary individuals and initiatives whose dedication to innovation is driving positive change in medicine and health care.
Maternal obesity predicts heart disease risk better than pregnancy complications
Pregnancy complications such as preeclampsia and gestational diabetes have recently been associated with a higher risk of developing heart disease later in life. But a new Northwestern Medicine study has found obesity before or during pregnancy is the actual root cause of future cardiovascular disease.
Heart disease risk, prevention and management redefined
Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association’s flagship journal Circulation.
Baylor Scott & White Presents Research At The Heart Failure Society of America Annual Scientific Meeting 2023
The Heart Failure Society of America (HFSA) is a multidisciplinary organization working to improve and expand heart failure care through collaboration, education, research, innovation and advocacy. Its annual scientific meeting held Oct. 6-9, in Cleveland offers the best heart failure…
Mount Sinai Announces Partnership With the Chiba Institute of Technology in Japan Focusing on Artificial Intelligence to Transform Cardiovascular Research
Agreement aims to help make clinical trials more efficient and lead to faster advances in patient care
Largest-Ever Genetic Study of Suicide Finds New Risk Factors
The reasons why people attempt suicide are complex and include external triggers like trauma and stress, as well as inherited genetic factors. A new study has identified 12 DNA variants, or variations in the human genetic code, that are associated with risk of attempting suicide.
Preschoolers From Low-Income Families May Have Worse Health and Benefit Less From Health Promotion Interventions Than Children With Higher Socioeconomic Status
Mount Sinai study focused on Harlem preschools emphasizes the need for specialized health promotion programs in classrooms starting at an early age
Mount Sinai Researchers Develop Novel, Automated Measure of Sleep Studies to Determine Severity of Obstructive Sleep Apnea
New method can predict risks of cardiovascular disease, mortality in sleep apnea patients
New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes
A diagnostic test, first offered in the United States at University Hospitals Harrington Heart & Vascular Institute, has now shown through a clinical study to significantly decrease cardiovascular mortality, reduce additional non-invasive heart testing, and increase cath lab efficiency.
Virtual drug quiets noise in heart tissue images
Researchers at Washington University in St. Louis have developed a new computational approach to removing movement in images of expanding and contracting heart cells and tissues. By computationally removing movement, the algorithm mimics a drug’s action in stopping the heart, without compromising cellular structure or tissue contractility.
CRF Announces TCT 2023 Late-Breaking Clinical Trials
The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical trials. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine.
MEDIA ADVISORY: Cedars-Sinai Experts Available to Discuss Safety, Benefits of Using Medications to Lose Weight
The science is unclear on exactly why an increasingly popular new class of federally approved diabetes and obesity medications work, but they do know that they are effective at helping people lose weight.
The Medical Minute: Pediatric congenital heart disease patients need help transitioning to adulthood
Parents can be so protective of a child with congenital heart disease they often forget what comes next. When should they start learning to take care of their own condition? Two Penn State Health experts share their views.
The Medical Minute: Understanding hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy can cause sudden death at any age – but particularly in young people. A Penn State Health heart surgeon discusses prevention.
Excess Testosterone Can Lead to Increased Cardiovascular Risks in People with Polycystic Ovary Syndrome
Article title: Testosterone-associated blood pressure dysregulation in women with androgen excess polycystic ovary syndrome Authors: Tori Stone, Licy L. Yanes Cardozo, Toni N. Oluwatade, Cheryl A. Leone, Melanie Burgos, Faith Okifo, Lubna Pal, Jane F. Reckelhoff, Nina. S. Stachenfeld From…